Decreased secretion of amyloid precursor protein in Chinese hamster ovary cells overexpressing presenilin 1

Alzheimer's Reports

Volumn 2, Issue 4, 1999, Pages 231-239

  Verdile, Giuseppe ^a   Fraser, Paul E ^a,c   Schofield, Peter R ^d   Fisher, Christopher ^a   Helmerhorst, Erik ^b   Martins, Ralph N ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST VINCENT S HOSPITAL   (Australia)

^d CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22644451419     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ancolio K, Marambaud P, Dauch P and Checler F (1997). α-Secretase-derived product of β amyloid precursor is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem 69 2494-2499.
2. Ausubel FM, Brent R, Kingston R et al. (1991). Current Protocols in Molecular Biology Volume 2. John Wiley and Son, England.
3. Borchelt DR, Thinarkaran G, Eckman CB et al. (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
4. Borg JP, Ooi J, Levy E and Margolis B (1996). The phosphotyrosine interaction domains of X11 and Fe65 bind to distinct sites on the YENPTY motif of amyloid precursor protein Mol Cell Biol 16, 6229-6241.
5. Caporaso GL, Gandy SE, Buxbaum JD and Greengard P (1992). Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89, 2252-2256.
6. Citron M, Westaway D, Xia W, Carlson G et al. (1997). Mutant Presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein on both transfected cells and transgenic mice. Nature Med 3, 67-72.
7. De Strooper B, Beullens M, Contreras B and Craessaerts K (1997). Post-translational modifications, subcellular localisation and membrane orientation of the Alzheimer's disease associated presenilin's. J Biol Chem 272, 3590-3598.
8. De Strooper B, Saftig P, Craessaerts K et al. (1998). Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387-390.
9. De Strooper B, Annett W, Cuprous P et al. (1999). A presenilin-1-dependent gamma secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-521.
10. Esch FS, Kim PS, Beattie EC et al. (1990). Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124
11. Fiore F, Zambrano N, Minopoli G et al. (1995). The regions of the Fe65 protein homologous to the phosphotyrosine interaction/ phosphotyrosine binding domain of She bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 270, 30853-30856.
12. Kim T, Pettingel WH, Jung Y, Kovacs DM and Tanzi RE (1997). Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376.
13. Lai A, Sisodia SS and Towbridge IS (1995). Characterisation of sorting signals in the beta-amyloid precursor protein cytoplasmic domain. J Biol Chem 270, 3565-3573.
14. Lee MK, Borchelt DR, Kim G et al. (1997). Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nature Med 3, 756-760.
15. Lemere CA, Lopera F, Kosik KS et al. (1996). The E280A presenilin Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med 2, 1146-1150.
16. L'Hernault SWL and Arduengo PM (1992). Mutation of a putative sperm membrane protein in Caenorhabiditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 119, 55-67.
17. Levitan D and Greenwald I (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabiditis elegans S12 Alzheimer's disease gene. Nature 377, 351-354.
18. Levitan D, Doyle TG, Brousseau D et al. (1996). Assessment of normal and mutant human presenilin function in Caenorhabiditis elegans. Proc Natl Acad Sci USA 93, 14940-14944.
19. Levy-Lahad E. Wasco W. Poorkaj P et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
20. Martins RN, Turner BA, Carroll RT et al. (1995). High levels of amyloid-β-protein from S182(Glu246) familial Alzheimer's disease. NeuroReport 7, 217-220.
21. Masters CL, Simms G, Weinman NA et al. (1985). Amyloid plaque core protein in Alzheimer's disease and Down Syndrome. Proc Natl Acad Sci USA 82, 4245-4249.
22. Miller JR and Moon RT (1996). Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes and Devel 10, 2527-2539.
23. Murayama M, Tanaka S, Palacino J et al. (1998). Direct association of presenilin-1 with beta-catenin. FEBS letts 433, 73-77
24. Nishimura M, Yu G, Levesque G et al. (1999). Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nature Med 5, 164-169.
25. Nordstedt C, Caporaso GL, Thyberg J et al. (1993). Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem 268, 608-612.
26. Pahlsson P, Shakin-Eshelmen S and Spitalnik SL (1992). N-linked glycosylated of β-amyloid precursor protein. Biochem Biophys Res Comm 189, 1667-1673.
27. Podlisny MB, Citron M, Amarante P et al. (1997). Presenilin proteins undergoheterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 3, 325-337.
28. Ratovitski T, Slunt HH, Thinakaran G et al. (1997). Endoproteolytic processing and stabilisation of wild-type and mutant presenilin. J Biol Chem 272, 24536-24541.
29. Ray W, Yao M, Nowotny P et al. (1999). Evidence for a physical interaction between presenilin and Notch. Proc Natl Acad Sci USA 96, 3263-3268.
30. Sastre M, Turner RS and Levy E (1998). X11 interaction with beta-amyloid precursor protein modulates its cellular stabilisation and reduces amyloid beta-protein secretion. J Biol Chem 273, 22351-22357.
31. Scheuner D, Eckman C, Jensen M et al. (1996). Fibroblasts from carriers of familial AD Linked to chromosome 14 show increased Aβ production. Nature Med 2, 864-870.
32. Seubert P, Oltersdorf T, Lee MG et al. (1993). Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260-263.
33. Sisodia SS (1992). Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci. USA 89, 6075-6079.
34. Thinakaran G, Borchelt DR, Lee M et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190.
35. Tomlinson BE (1992). Ageing and the dementias. In:Adams JH and Duchen LW (eds). Oxford University Press, New York: pp. 1284-1410.
36. Waragai M, Imafuku I, Takeuchi S et al. (1997). Presenilin 1 binds to amyloid precursor protein directly. Biochem Biophys Res Comm 239, 480-482.
37. Weidemann A, Konig G, Bunke D et al. (1989). Identification, biogenesis and localisation of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126.
38. Weidemann A, Paliga K, Durrwang C et al. (1997). Formation of stable complexes between two Alzheimer's disease gene products: presenilin 2 and β-amyloid precursor protein. Nature Med 3, 328-332.
39. Wolfe MS, Xia W, Ostaszewski BL et al. (1999). Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-517.
40. Xia W, Zhang J, Kholodenko D et al. (1997a). Enhanced production and oligomerization of the 42-residue Amyloid (β)-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 272, 7977-7982.
41. Xia W, Zhang J, Perez R et al. (1997b). Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer's disease. Proc Natl Acad Sci USA 94, 8208-8213.
42. Yu G, Chen F, Levesque G and Nishimura M (1998). The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem 273, 16470-16475.